These findings may suggest a systemic hypersensitivity reaction or other condition requiring evaluation
Ready to Lose Weight and Keep It Off
Compounded GLP-1s are a glucagon-like peptide-1 (GLP-1) receptor agonist which may be used for chronic weight management, along with a reduced calorie diet and increased physical activity, for people with an initial body mass index (BMI) of: 30 kg/m2 or greater (obesity) or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia)
Because experimental outcomes depend on model design, concentration selection, solvent system, controls, storage history, and analytical endpoints, all conclusions should be drawn only within the limits of the laboratory protocol
2014 Oct
Patients should work closely with their healthcare provider to implement alternative diabetes management or weight maintenance strategies before stopping semaglutide